<SEC-DOCUMENT>0001193125-23-221501.txt : 20230825
<SEC-HEADER>0001193125-23-221501.hdr.sgml : 20230825
<ACCEPTANCE-DATETIME>20230825161553
ACCESSION NUMBER:		0001193125-23-221501
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20230823
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230825
DATE AS OF CHANGE:		20230825

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KEWAUNEE SCIENTIFIC CORP /DE/
		CENTRAL INDEX KEY:			0000055529
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY APPARATUS & FURNITURE [3821]
		IRS NUMBER:				380715562
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-05286
		FILM NUMBER:		231208471

	BUSINESS ADDRESS:	
		STREET 1:		2700 W FRONT ST
		CITY:			STATESVILLE
		STATE:			NC
		ZIP:			28677
		BUSINESS PHONE:		7048737202

	MAIL ADDRESS:	
		STREET 1:		P O BOX 1842
		CITY:			STATESVILLE
		STATE:			NC
		ZIP:			28687-1842

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KEWAUNEE SCIENTIFIC EQUIPMENT CORP /DE/
		DATE OF NAME CHANGE:	19861216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KEWAUNEE MANUFACTURING CO
		DATE OF NAME CHANGE:	19680108
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d543464d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:kequ="http://www.kewaunee.com/20230823" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2023-08-23_to_2023-08-23">KEWAUNEE SCIENTIFIC CORP /DE/</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-08-23_to_2023-08-23">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-08-23_to_2023-08-23">0000055529</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="kequ-20230823.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-08-23_to_2023-08-23"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000055529</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-08-23</xbrli:startDate> <xbrli:endDate>2023-08-23</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-08-23_to_2023-08-23">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-08-23_to_2023-08-23" format="ixt:datemonthdayyearen">August&#160;23, 2023</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">Kewaunee Scientific Corporation</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-08-23_to_2023-08-23" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-08-23_to_2023-08-23">0-5286</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-08-23_to_2023-08-23">38-0715562</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or other jurisdiction<br />of incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(I.R.S. Employer<br />Identification No.)</span></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-08-23_to_2023-08-23">2700 West Front Street</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-08-23_to_2023-08-23">Statesville</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-08-23_to_2023-08-23" format="ixt-sec:stateprovnameen">North Carolina</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-08-23_to_2023-08-23">28677</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <span style="white-space:nowrap"><span style="white-space:nowrap"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-08-23_to_2023-08-23">704</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-08-23_to_2023-08-23">873-7202</ix:nonNumeric></span></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report.)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name&#160;of&#160;each&#160;exchange<br />on which&#160;registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-08-23_to_2023-08-23">Common Stock, $2.50 par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-08-23_to_2023-08-23">KEQU</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-08-23_to_2023-08-23" format="ixt-sec:exchnameen">NASDAQ Global Market</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-08-23_to_2023-08-23" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-08-23_to_2023-08-23" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-08-23_to_2023-08-23" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-08-23_to_2023-08-23" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-08-23_to_2023-08-23" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kewaunee Scientific Corporation (the &#8220;Company&#8221;) held its Annual Meeting of Shareholders on August&#160;23, 2023 (the &#8220;Annual Meeting&#8221;). At the Annual Meeting, the Company&#8217;s stockholders approved the Kewaunee Scientific Corporation 2023 Omnibus Incentive Plan, as amended (the &#8220;Plan&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A summary of the Plan was included in the Company&#8217;s definitive proxy statement filed with the Securities and Exchange Commission on July&#160;6, 2023 (the &#8220;Proxy Statement&#8221;), as supplemented by the additional definitive proxy soliciting material filed with the Securities and Exchange Commission on August&#160;10, 2023 (the &#8220;Additional Soliciting Material&#8221;). The Proxy Statement and the Additional Soliciting Material are incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The summary of the Plan contained in the Proxy Statement, as supplemented by the Additional Soliciting Material, is qualified in its entirety by reference to the full text of the Plan, which is filed as Exhibit 10.1 to this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.07</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Submission of Matters to a Vote of Security Holders. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) and (b)&#160;&#160;&#160;&#160;On August&#160;23, 2023, the Company held the Annual Meeting. At the Annual Meeting, the Company&#8217;s stockholders voted on the matters set forth below. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.&#160;&#160;&#160;&#160;Each of the nominees named below was <span style="white-space:nowrap">re-elected</span> as a Class&#160;I director for a three-year term as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:84%;border:0;margin:0 auto">


<tr>

<td style="width:71%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name&#160;of&#160;Nominee</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">For</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Withheld</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold"><span style="white-space:nowrap">Non-Votes</span></span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas D. Hull III</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,912,637</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">6,896</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">560,185</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David S. Rhind</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,666,638</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">252,895</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">560,185</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John D. Russell</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,910,387</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">9,146</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">560,185</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.&#160;&#160;&#160;&#160;The appointment of the independent registered public accounting firm of FORVIS, LLP as the Company&#8217;s independent auditors for fiscal year 2024 was ratified as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:76%;border:0;margin:0 auto">


<tr>

<td style="width:34%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstained</p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom" align="center">2,476,494</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">57</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">3,167</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.&#160;&#160;&#160;&#160;The compensation of the Company&#8217;s named executive officers was approved on an advisory basis as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border:0;margin:0 auto">


<tr>

<td style="width:24%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:25%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:24%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstained</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom" align="center">1,839,983</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">65,792</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">13,758</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">560,185</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.&#160;&#160;&#160;&#160;The Kewaunee Scientific Corporation 2023 Omnibus Incentive Plan, as amended, was approved as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:84%;border:0;margin:0 auto">


<tr>

<td style="width:24%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:25%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:24%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstained</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom" align="center">1,419,893</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">498,027</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">1,613</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">560,185</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman;font-weight:bold">(d) Exhibits: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Exhibit<br />No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d543464dex101.htm">Kewaunee Scientific Corporation 2023 Omnibus Incentive Plan, as amended. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Signature </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:46%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:2%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(Registrant)</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Kewaunee Scientific Corporation</p></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date:August&#160;25, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;font-weight:bold">/s/ Donald T. Gardner III</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Donald T. Gardner III</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Vice President, Finance and Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d543464dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KEWAUNEE SCIENTIFIC CORPORATION, AS AMENDED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2023 OMNIBUS INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kewaunee Scientific Corporation sets forth herein the terms of its 2023 Omnibus Incentive Plan, as amended. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>PURPOSE </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan is intended to enhance the ability of the Company and its Affiliates to attract and retain highly qualified officers, Nonemployee
Directors, employees, consultants and advisors, and to motivate such individuals to serve the Company and its Affiliates and to expend maximum effort to improve the business results and earnings of the Company, by providing to such persons an
opportunity to acquire or increase a direct proprietary interest in the operations and future success of the Company. To this end, the Plan provides for the grant of stock options, stock appreciation rights (&#147;SARs&#148;), restricted stock,
restricted stock units (&#147;RSUs&#148;), unrestricted stock, Other Share-based Awards and cash awards. Any of these awards may, but need not, be made as performance incentives to reward attainment of performance goals in accordance with the terms
hereof. Upon the Plan becoming effective, no further awards shall be made under any of the Prior Plans. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DEFINITIONS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of interpreting the Plan and related documents (including Award Agreements), the following definitions shall apply: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Acquiror</B>&#148; shall have the meaning set forth in <B>Section</B><B></B><B>&nbsp;15.2.1</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Affiliate</B>&#148; means any company or other trade or business that &#147;controls,&#148; is &#147;controlled by&#148; or is
&#147;under common control with&#148; the Company within the meaning of Rule 405 of Regulation C under the Securities Act, including any Subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Annual Incentive Award</B>&#148; means a cash-based performance award with a performance period that is the Company&#146;s fiscal
year or other <FONT STYLE="white-space:nowrap">12-month</FONT> (or shorter) performance period as specified under the terms of the Award as approved by the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Award</B>&#148; means a grant under the Plan of an Option, SAR, Restricted Stock, RSU, Other Share-based Award or cash award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Award Agreement</B>&#148; means a written agreement between the Company and a Participant, or notice from the Company or an Affiliate
to a Participant that evidences and sets out the terms of an Award. &#147;<B>Board</B>&#148; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Business Combination</B>&#148; shall have the meaning set forth in <B>Section</B><B></B><B>&nbsp;15.2.2</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Cause</B>&#148; shall be defined as that term or any term of similar import is defined in the Participant&#146;s offer letter or
other applicable employment agreement; or, if there is no such definition, &#147;Cause&#148; means, as determined by the Company in its sole discretion and unless otherwise provided in the applicable Award Agreement: (i)&nbsp;the commission of any
act by a Participant constituting financial dishonesty against the Company or its Affiliates (which act would be chargeable as a crime under applicable law); (ii)&nbsp;a Participant&#146;s engaging in any other act of dishonesty, fraud, intentional
misrepresentation, moral turpitude, illegality or harassment that would: (a)&nbsp;materially adversely affect the business or the reputation of the Company or any of its Affiliates with their respective current or prospective customers, suppliers,
lenders or other third parties with whom such entity does or might do business or (b)&nbsp;expose the Company or any of its Affiliates to a risk of civil or criminal legal damages, liabilities or penalties;
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(iii)&nbsp;the repeated failure by a Participant to follow the directives of the chief executive officer of the Company or any of its Affiliates or the Board; or (iv)&nbsp;any material
misconduct, violation of the Company&#146;s or Affiliates&#146; policies or willful and deliberate <FONT STYLE="white-space:nowrap">non-performance</FONT> of duty by the Participant in connection with the business affairs of the Company or its
Affiliates. A Separation from Service for Cause shall be deemed to include a determination by the Company in its sole discretion following a Participant&#146;s Separation from Service that circumstances existing prior to such Separation from Service
would have entitled the Company or an Affiliate to have terminated the Participant&#146;s service for Cause. All rights a Participant has or may have under the Plan shall be suspended automatically during the pendency of any investigation by the
Company, or during any negotiations between the Company and the Participant, regarding any actual or alleged act or omission by the Participant of the type described in the applicable definition of Cause. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Change in Control</B>&#148; shall have the meaning set forth in <B>Section</B><B></B><B>&nbsp;15.2.2</B>. &#147;<B>Code</B>&#148;
means the Internal Revenue Code of 1986. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Committee</B>&#148; means the Compensation Committee of the Board, or such other
committee as determined by the Board. The Compensation Committee of the Board may designate a subcommittee of its members to serve as the Committee (to the extent the Board has not designated another person, committee or entity as the Committee).
The Board will cause the Committee to satisfy the applicable requirements of any securities exchange on which the Common Stock may then be listed. For purposes of Awards to Participants who are subject to Section&nbsp;16 of the Exchange Act,
Committee means all of the members of the Compensation Committee who are &#147;nonemployee directors&#148; within the meaning of Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> adopted under the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Company</B>&#148; means Kewaunee Scientific Corporation, a Delaware corporation, or any successor to it. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Common Stock</B>&#148; means the common stock of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Consultant</B>&#148; means a consultant or advisor that provides bona fide services to the Company or any Affiliate and who qualifies
as a consultant or advisor under Form <FONT STYLE="white-space:nowrap">S-8.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Disability</B>&#148; shall be defined as that
term or any term of similar import is defined in the Participant&#146;s offer letter or other applicable employment agreement; or, if there is no such definition, &#147;Disability&#148; means, as determined by the Company in its sole discretion and
unless otherwise provided in the applicable Award Agreement, the Participant is unable to perform each of the essential duties of such Participant&#146;s position by reason of a medically determinable physical or mental impairment which is
potentially permanent in character or which can be expected to last for a continuous period of not less than 12 months; <I>provided</I>, <I>however</I>, that, with respect to rules regarding expiration of an Incentive Stock Option following
termination of the Participant&#146;s employment, &#147;Disability&#148; means &#147;permanent and total disability&#148; as set forth in Code Section&nbsp;22(e)(3). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Effective Date</B>&#148; means the date the Plan is approved by the Stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Exchange Act</B>&#148; means the Securities Exchange Act of 1934. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Fair Market Value</B>&#148; of a Share as of a particular date shall mean, if the Common Stock is listed on a national securities
exchange, <B>except as set forth below, </B>the closing or last price of the Common Stock on the composite tape or other comparable reporting system for the applicable date, or if the applicable date is not a trading day, the trading day most
immediately preceding the applicable date. If the Shares are not listed on a national securities exchange, or the value of such Shares is not otherwise determinable, Fair Market Value of a Share as of a particular date shall mean the value as
determined by the Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Family Member</B>&#148; means a person who is a spouse, former spouse, child,
stepchild, grandchild, parent, stepparent, grandparent, niece, nephew, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mother-in-law,</FONT></FONT>
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">father-in-law,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">son-in-law,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">daughter-in-law,</FONT></FONT> brother, sister, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">brother-in-law</FONT></FONT> or
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">sister-in-law,</FONT></FONT> including adoptive relationships, of the applicable individual, any person sharing the applicable individual&#146;s household (other than a tenant or
employee), a trust in which any one or more of these persons have more than 50% of the beneficial interest, a foundation in which any one or more of these persons (or the applicable individual) control the management of assets, and any other entity
in which one or more of these persons (or the applicable individual) own more than 50% of the voting interests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Grant
Date</B>&#148; means the latest to occur of (i)&nbsp;the date as of which the Board approves an Award, (ii)&nbsp;the date on which the recipient of an Award first becomes eligible to receive an Award under <B>Section</B><B></B><B>&nbsp;6</B> or
(iii)&nbsp;such other date as may be specified by the Board in the Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Incentive Stock Option</B>&#148; means an
&#147;incentive stock option&#148; within the meaning of Code Section&nbsp;422. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Incumbent Directors</B>&#148; shall have the
meaning set forth in <B>Section</B><B></B><B>&nbsp;15.2.2</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>New Shares</B>&#148; shall have the meaning set forth in
<B>Section</B><B></B><B>&nbsp;15.1</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Nonemployee Director</B>&#148; means a member of the Board or the board of directors of
an Affiliate, in each case who is not an officer or employee of the Company or any Affiliate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Nonqualified Stock
Option</B>&#148; means an Option that is not an Incentive Stock Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Option</B>&#148; means an option to purchase one or more
Shares pursuant to the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Option Price</B>&#148; means the exercise price for each Share subject to an Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Other Share-based Awards</B>&#148; means Awards consisting of Share units, or other Awards, valued in whole or in part by reference
to, or otherwise based on, Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Participant</B>&#148; shall mean a person who, as a Service Provider, has been granted an
Award under the Plan; <I>provided</I> that in the case of the death or Disability of a Participant, the term &#147;Participant&#148; refers to the Participant&#146;s estate or other legal representative acting in a fiduciary capacity on behalf of
the Participant under applicable state law and court supervision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Plan</B>&#148; means this Kewaunee Scientific Corporation 2023
Omnibus Incentive Plan, as amended from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Policy</B>&#148; shall have the meaning set forth in
<B>Section</B><B></B><B>&nbsp;3.2.2</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Prior Plans</B>&#148; means, collectively, (i)&nbsp;the Kewaunee Scientific Corporation
2008 Key Employee Stock Option Plan and (ii)&nbsp;the Kewaunee Scientific Corporation 2017 Omnibus Incentive Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Purchase
Price</B>&#148; means the purchase price for each Share pursuant to a grant of Restricted Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Restricted Stock</B>&#148;
means restricted Shares, awarded to a Participant pursuant to <B>Section</B><B></B><B>&nbsp;10</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Restricted Stock
Unit</B>&#148; or &#147;<B>RSU</B>&#148; means a bookkeeping entry representing the equivalent of Shares, awarded to a Participant pursuant to <B>Section</B><B></B><B>&nbsp;10</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>SAR Exercise Price</B>&#148; means the per Share exercise price of a SAR granted to a Participant under
<B>Section</B><B></B><B>&nbsp;9</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>SEC</B>&#148; means the United States Securities and Exchange Commission. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Section</B><B></B><B>&nbsp;409A</B>&#148; means Code Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Securities Act</B>&#148; means the Securities Act of 1933. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Separation from Service</B>&#148; means the termination of the applicable Participant&#146;s employment with, and performance of
services for, the Company and each Affiliate. A Participant employed by, or performing services for, an Affiliate or a division of the Company or an Affiliate shall not be deemed to incur a Separation from Service if such Affiliate or division
ceases to be an Affiliate or division of the Company, as the case may be, and the Participant immediately thereafter becomes an employee of (or service provider to), or member of the board of directors of, the Company or an Affiliate or a successor
company or an affiliate or subsidiary thereof. Approved temporary absences from employment because of illness, vacation or leave of absence and transfers among the Company and its Affiliates shall not be considered Separations from Service.
Notwithstanding the foregoing, with respect to any Award that constitutes nonqualified deferred compensation under Section&nbsp;409A, &#147;Separation from Service&#148; shall mean a &#147;separation from service&#148; as defined under
Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Service Period</B>&#148; shall have the meaning set forth in <B>Section</B><B></B><B>&nbsp;10.1</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Service Provider</B>&#148; means an employee, officer, Nonemployee Director or Consultant of the Company or an Affiliate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Share</B>&#148; means a share of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Stock Appreciation Right</B>&#148; or &#147;<B>SAR</B>&#148; means a right granted to a Participant pursuant to
<B>Section</B><B></B><B>&nbsp;9</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Stockholders</B>&#148; means the stockholders of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Subsidiary</B>&#148; means any &#147;subsidiary corporation&#148; of the Company within the meaning of Code Section&nbsp;424(f). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Substitute Award</B>&#148; means any Award granted in assumption of or in substitution for an award of a company or business acquired
by the Company or an Affiliate or with which the Company or an Affiliate combines. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Ten Percent Stockholder</B>&#148; means an
individual who owns more than 10% of the total combined voting power of all classes of outstanding stock of the Company, its parent or any of its Subsidiaries. In determining stock ownership, the attribution rules of Code Section&nbsp;424(d) shall
be applied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Termination Date</B>&#148; means the date that is 10 years after the Effective Date, unless the Plan is earlier
terminated by the Board under <B>Section</B><B></B><B>&nbsp;5.2</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Voting Securities</B>&#148; shall have the meaning set
forth in <B>Section</B><B></B><B>&nbsp;15.2.2</B>. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>ADMINISTRATION OF THE PLAN </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.1. General </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board
shall have such powers and authorities related to the administration of the Plan as are consistent with the Company&#146;s certificate of incorporation and bylaws and applicable law. The Board shall have the power and authority to delegate its
responsibilities hereunder to the Committee, which shall have full authority to act in accordance with its charter, and with respect to the power and authority of the Board to act hereunder, all references to the Board shall be deemed to include a
reference to the Committee, unless such power or authority is specifically reserved by the Board. Except as specifically provided in <B>Section</B><B></B><B>&nbsp;14</B> or as otherwise may be required by applicable
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
law, regulatory requirement or the certificate of incorporation or the bylaws of the Company, the Board shall have full power and authority to take all actions and to make all determinations
required or provided for under the Plan, any Award or any Award Agreement, and shall have full power and authority to take all such other actions and make all such other determinations not inconsistent with the specific terms and provisions of the
Plan that the Board deems to be necessary or appropriate to the administration of the Plan. The Committee shall administer the Plan; <I>provided</I>, <I>however</I>, the Board shall retain the right to exercise the authority of the Committee to the
extent consistent with applicable law and the applicable requirements of any securities exchange on which the Common Stock may then be listed. All actions, determinations and decisions by the Board or the Committee under the Plan or any Award
Agreement, or with respect to any Award, shall be in the sole discretion of the Board and shall be final, binding and conclusive on all persons. Without limitation, the Board shall have full and final power and authority, subject to the other terms
of the Plan, to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">designate Participants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">determine the type or types of Awards to be made to Participants; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">determine the number of Shares to be subject to an Award; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">establish the terms of each Award (including the Option Price of any Option, the nature and duration of any
restriction or condition (or provision for lapse thereof) relating to the vesting, exercise, transfer or forfeiture of an Award or the Shares subject thereto and any terms or conditions that may be necessary to qualify Options as Incentive Stock
Options); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">prescribe the form of each Award Agreement; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">amend, modify or supplement the terms of any outstanding Award including the authority, in order to effectuate
the purposes of the Plan, to modify Awards to foreign nationals or individuals who are employed outside the United States to recognize differences in local law, tax policy or custom. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.2. Separation from Service for Cause; Clawbacks</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>3.2.1. Separation from Service for Cause</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company may annul an Award if the Participant incurs a Separation from Service for Cause. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>3.2.2. Clawbacks</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">All
awards, amounts or benefits received or outstanding under the Plan shall be subject to clawback, cancellation, recoupment, rescission, payback, reduction or other similar action in accordance with the terms of any Company clawback or similar policy
(the &#147;<B>Policy</B>&#148;) or any applicable law related to such actions, as may be in effect from time to time. A Participant&#146;s acceptance of an Award shall be deemed to constitute the Participant&#146;s acknowledgement of and consent to
the Company&#146;s application, implementation and enforcement of any applicable Policy that may apply to the Participant, whether adopted prior to or following the Effective Date, and any provision of applicable law relating to clawback,
cancellation, recoupment, rescission, payback or reduction of compensation, and the Participant&#146;s agreement that the Company may take such actions as may be necessary to effectuate any such policy or applicable law, without further
consideration or action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.3. Deferral Arrangement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may permit or require the deferral of any Award payment into a deferred compensation arrangement, subject to such rules and
procedures as it may establish and in accordance with Section&nbsp;409A, which may include provisions for the payment or crediting of interest or dividend equivalents, including converting such credits into deferred Share units. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.4. No Liability </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No member of the Board or of the Committee shall be liable for any action or determination made in good faith with respect to the Plan, any
Award or Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.5. Book Entry </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding any other provision of the Plan to the contrary, the Company may elect to satisfy any requirement under the Plan for the
delivery of stock certificates through the use of book entry. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.6. No Repricing </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding any provision herein to the contrary, the repricing of Options or SARs is prohibited without prior approval of the
Stockholders. For this purpose, a &#147;repricing&#148; means any of the following (or any other action that has the same effect as any of the following): (i) changing the terms or conditions of an Option or SAR to lower its Option Price or SAR
Exercise Price; (ii)&nbsp;any other action that is treated as a &#147;repricing&#148; under generally accepted accounting principles; and (iii)&nbsp;repurchasing for cash or canceling an Option or SAR at a time when its Option Price or SAR Exercise
Price is greater than the Fair Market Value of the underlying Shares in exchange for another Award, unless the cancellation and exchange occurs in connection with a change in capitalization or similar change under
<B>Section</B><B></B><B>&nbsp;15</B>. A cancellation and exchange under clause (iii)&nbsp;would be considered a &#147;repricing&#148; regardless of whether it is treated as a &#147;repricing&#148; under generally accepted accounting principles and
regardless of whether it is voluntary on the part of the Participant. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>STOCK SUBJECT TO THE PLAN </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.1. Authorized Number of Shares </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to adjustment under <B>Section</B><B></B><B>&nbsp;15</B>, the aggregate number of Shares authorized to be awarded under the Plan is
374,633 as of the Effective Date. In addition, Shares underlying any outstanding award granted under a Prior Plan that, following the Effective Date, expires, or is terminated, surrendered or forfeited (including withheld by the Company) for any
reason without issuance of Shares shall be available for the grant of new Awards and correspondingly shall increase the aggregate number of Shares authorized to be awarded under the Plan. As provided in <B>Section</B><B></B><B>&nbsp;1</B>, no new
awards shall be granted under either of the Prior Plans following the Effective Date. Shares issued under the Plan may consist in whole or in part of authorized but unissued Shares, treasury Shares or Shares purchased on the open market or
otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.2. Share Counting </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>4.2.1.</B> Any Award settled in cash shall not be counted as issued Shares for any purpose under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>4.2.2.</B> If any Award expires, or is terminated, surrendered or forfeited, in whole or in part, the unissued Shares covered by such Award
shall again be available for the grant of Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>4.2.3.</B> If Shares issued pursuant to the Plan are repurchased by, or are
surrendered or forfeited to the Company at no more than cost, such Shares shall again be available for the grant of Awards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>4.2.4.</B> If Shares issuable upon exercise, vesting or settlement of an Award, or Shares
owned by a Participant (which are not subject to any pledge or other security interest), are surrendered or tendered to the Company, or withheld by the Company, in payment of the Option Price or Purchase Price of an Award or any taxes required to be
withheld in respect of an Award, in each case, in accordance with the terms of the Plan and any applicable Award Agreement, such surrendered or tendered (or withheld) Shares shall again be available for the grant of Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>4.2.5.</B> Substitute Awards shall not be counted against the number of Shares available for the grant of Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.3. Award Limits </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>4.3.1. Incentive Stock Options</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Subject to adjustment under <B>Section</B><B></B><B>&nbsp;15</B>, 374,633 Shares available for issuance under the Plan shall be available for
issuance as Incentive Stock Options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>4.3.2. Director Awards</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The maximum value of Awards granted during any calendar year to any Nonemployee Director, taken together with any cash fees paid to such
Nonemployee Director during the calendar year and the value of awards granted to the Nonemployee Director under any other equity compensation plan of the Company or an Affiliate during the calendar year, in each case for such Nonemployee
Director&#146;s services as a Nonemployee Director, shall not exceed the following in total value (calculating the value of any Awards or other equity compensation plan awards based on the fair market value as of grant date in accordance with U.S.
generally accepted accounting principles): (i) $250,000 for the nonemployee Chair of the Board and (ii) $200,000 for each Nonemployee Director other than the Chair of the Board; <I>provided, however</I>, that awards granted to Nonemployee Directors
upon their initial election to the Board or the board of directors of an Affiliate shall not be counted towards the limit under this<B> Section</B><B></B><B>&nbsp;4.3.2</B>. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>EFFECTIVE DATE, DURATION AND AMENDMENTS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.1. Term </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan
shall be effective as of the Effective Date. The Plan shall terminate automatically on the <FONT STYLE="white-space:nowrap">10-year</FONT> anniversary of the Effective Date and may be terminated on any earlier date as provided in
<B>Section</B><B></B><B>&nbsp;5.2</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.2. Amendment and Termination of the Plan </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may, at any time and from time to time, amend, suspend or terminate the Plan as to any Awards which have not been made. An amendment
shall be contingent on approval of the Stockholders to the extent stated by the Board, required by applicable law or required by applicable securities exchange listing requirements. No Awards shall be made after the Termination Date. The applicable
terms of the Plan, and any terms applicable to Awards granted prior to the Termination Date, shall survive the termination of the Plan and continue to apply to such Awards. No amendment, suspension or termination of the Plan shall, without the
consent of the Participant, materially impair such Participant&#146;s rights under any Award theretofore awarded. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>AWARD ELIGIBILITY AND LIMITATIONS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.1. Service Providers </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to this <B>Section</B><B></B><B>&nbsp;6</B>, Awards may be made to any Service Provider as the Board may determine and designate from
time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.2. Successive Awards </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An eligible person may receive more than one Award, subject to such restrictions as are provided herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.3. Stand-Alone, Additional, Tandem, and Substitute Awards </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Awards may be granted either alone or in addition to, in tandem with, or in substitution or exchange for, any other Award or any award granted
under another plan of the Company, any Affiliate or any business entity to be acquired by the Company or an Affiliate, or any other right of a Participant to receive payment from the Company or any Affiliate. Such additional, tandem or substitute or
exchange Awards may be granted at any time. If an Award is granted in substitution or exchange for another award, the Board shall have the right to require the surrender of such other award in consideration for the grant of the new Award. Subject to
the requirements of applicable law, the Board may make Awards in substitution or exchange for any other award under another plan of the Company, any Affiliate or any business entity to be acquired by the Company or an Affiliate. In addition, Awards
may be granted in lieu of cash compensation, including in lieu of cash amounts payable under other plans of the Company or any Affiliate, in which the value of Shares subject to the Award is equivalent in value (as determined by the Committee in its
sole discretion) to the cash compensation (for example, RSUs or Restricted Stock). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>AWARD AGREEMENT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The grant of any Award may be contingent upon the Participant executing an appropriate Award Agreement, in such form or forms as the Board
shall from time to time determine. Acceptance of the Award constitutes acceptance of all terms of the Plan and the notice. Award Agreements granted from time to time or at the same time need not contain similar provisions but shall be consistent
with the terms of the Plan. Each Award Agreement evidencing an Award of Options shall specify whether such Options are intended to be Nonqualified Stock Options or Incentive Stock Options, and in the absence of such specification such options shall
be deemed Nonqualified Stock Options. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>TERMS AND CONDITIONS OF OPTIONS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.1. Option Price </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Option Price of each Option shall be fixed by the Board and stated in the related Award Agreement. The Option Price of each Option (except those that constitute Substitute Awards) shall be at least the Fair Market Value on the Grant Date;
<I>provided</I>, <I>however</I>, that in the event that a Participant is a Ten Percent Stockholder as of the Grant Date, the Option Price of an Option granted to such Participant that is intended to be an Incentive Stock Option shall be not less
than 110&nbsp;percent of the Fair Market Value on the Grant Date. In no case shall the Option Price of any Option be less than the par value of a Share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.2. Vesting </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to
<B>Section</B><B></B><B>&nbsp;8.3</B>, each Option shall become exercisable at such times and under such conditions (including performance requirements) as stated in the Award Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.3. Term </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Option shall terminate, and all rights to purchase Shares thereunder shall cease, upon the expiration of the Option term stated in the
Award Agreement not to exceed 10 years from the Grant Date, or under such circumstances and on such date prior thereto as is set forth in the Plan or as may be fixed by the Board and stated in the related Award Agreement; <I>provided</I>,
<I>however</I>, that in the event that the Participant is a Ten Percent Stockholder, an Option granted to such Participant that is intended to be an Incentive Stock Option at the Grant Date shall not be exercisable after the expiration of five years
from its Grant Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.4. Limitations on Exercise of Option </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding any other provision of the Plan, in no event may any Option be exercised, in whole or in part, (i)&nbsp;prior to the date the
Plan is approved by the Stockholders as provided herein or (ii)&nbsp;after the occurrence of an event which results in termination of the Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.5. Method of Exercise </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An Option that is exercisable may be exercised by the Participant&#146;s delivery of a notice of exercise to the Company, setting forth the
number of Shares with respect to which the Option is to be exercised, accompanied by full payment for the Shares. To be effective, notice of exercise must be made in accordance with procedures established by the Company from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.6. Rights of Holders of Options </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided in the applicable Award Agreement, an individual holding or exercising an Option shall have none of the rights of a
Stockholder until the Shares covered thereby are fully paid and issued to him or her. Notwithstanding the foregoing, and except as set forth in <B>Section</B><B></B><B>&nbsp;15</B>, until the Shares covered by an Option are fully paid and issued to
the holder thereof, no right to receive dividends or distributions will exist with respect to such Shares. Except as provided in <B>Section</B><B></B><B>&nbsp;15</B> or, subject to the preceding sentence, the related Award Agreement, no adjustment
shall be made for dividends, distributions or other rights for which the record date is prior to the date of such issuance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.7.
Delivery of Stock Certificates </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to <B>Section</B><B></B><B>&nbsp;3.5</B>, promptly after the exercise of an Option by a
Participant and the payment in full of the Option Price, such Participant shall be entitled to the issuance of a stock certificate or certificates evidencing his or her ownership of the Shares subject to the Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.8. Limitations on Incentive Stock Options </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An Option shall constitute an Incentive Stock Option only (i)&nbsp;if the Participant of such Option is an employee of the Company or any
Subsidiary of the Company; (ii)&nbsp;to the extent specifically provided in the related Award Agreement; and (iii)&nbsp;to the extent that the aggregate Fair Market Value (determined at the time the Option is granted) of the Shares with respect to
which all Incentive Stock Options held by such Participant become exercisable for the first time during any calendar year (under the Plan and all other plans of the Participant&#146;s employer and its Affiliates) does not exceed $100,000. This
limitation shall be applied by taking Options into account in the order in which they were granted. No Option shall be treated as an Incentive Stock Option unless the Plan has been approved by the Stockholders in a manner intended to comply with the
stockholder approval requirements of Code Section&nbsp;422(b)(1); <I>provided</I> that any Option intended to be an Incentive Stock Option shall not fail to be effective solely on account of a failure to obtain such approval, but rather such Option
shall be treated as a Nonqualified Stock Option unless and until such stockholder approval is obtained. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>TERMS AND CONDITIONS OF STOCK APPRECIATION RIGHTS (SARs) </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.1. Right to Payment </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A
SAR shall confer on the Participant a right to receive, upon exercise thereof, the excess of (i)&nbsp;the Fair Market Value on the date of exercise over (ii)&nbsp;the SAR Exercise Price, as determined by the Board. The Award Agreement for a SAR
(except those that constitute Substitute Awards) shall specify the SAR Exercise Price, which shall be fixed on the Grant Date as not less than the Fair Market Value on that date. SARs may be granted alone or in conjunction with all or part of an
Option or at any subsequent time during the term of such Option or in conjunction with all or part of any other Award. A SAR granted in tandem with an outstanding Option following the Grant Date of such Option shall have a grant price that is equal
to the Option Price; <I>provided</I>, <I>however</I>, that the SAR&#146;s grant price may not be less than the Fair Market Value on the Grant Date of the SAR to the extent required by Section&nbsp;409A. Unless otherwise provided in the applicable
Award Agreement, an individual holding or exercising a SAR shall have none of the rights of a Stockholder until the Shares covered thereby are fully paid and issued to him or her. Notwithstanding the foregoing, and except as set forth in
<B>Section</B><B></B><B>&nbsp;15</B>, until the Shares covered by a SAR are fully paid and issued to the holder thereof, no right to receive dividends or distributions will exist with respect to such Shares. Except as provided in
<B>Section</B><B></B><B>&nbsp;15</B> or, subject to the preceding sentence, the related Award Agreement, no adjustment shall be made for dividends, distributions or other rights for which the record date is prior to the date of such issuance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.2. Other Terms </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Board shall determine at the Grant Date or thereafter, the time or times at which and the circumstances under which a SAR may be exercised in whole or in part (including based on achievement of performance goals or future service requirements), the
time or times at which SARs shall cease to be or become exercisable following Separation from Service or upon other conditions, the method of exercise, whether or not a SAR shall be in tandem or in combination with any other Award and any other
terms of any SAR. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.3. Term of SARs </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The term of a SAR granted under the Plan shall be determined by the Board; <I>provided</I>, <I>however</I>, that such term shall not exceed 10
years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.4. Payment of SAR Amount </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon exercise of a SAR, a Participant shall be entitled to receive payment from the Company (in cash or Shares, as set forth in the Award
Agreement) in an amount determined by multiplying: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the difference between the Fair Market Value on the date of exercise over the SAR Exercise Price; by
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the number of Shares with respect to which the SAR is exercised. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>TERMS AND CONDITIONS OF RESTRICTED STOCK AND RESTRICTED STOCK UNITS (RSUs) </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.1. Restrictions (applicable to Restricted Stock and RSUs) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the time of grant, the Board may establish a period of time (a &#147;<B>Service Period</B>&#148;) and any additional restrictions including
the satisfaction of company or individual performance objectives applicable to an Award of Restricted Stock or RSUs. Each Award of Restricted Stock or RSUs may be subject to a different Service Period and additional restrictions. Neither Restricted
Stock nor RSUs may be sold, transferred, assigned, pledged or otherwise encumbered or disposed of during the Service Period or prior to the satisfaction of any other applicable restrictions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.2. Delivery of Shares (applicable to Restricted Stock and RSUs) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to <B>Section</B><B></B><B>&nbsp;3.5</B>, upon the expiration or termination of any Service Period and the satisfaction of any other
conditions prescribed by the Board, the restrictions applicable to Shares of Restricted Stock or RSUs settled in Shares shall lapse, and, unless otherwise provided in the applicable Award Agreement, a stock certificate for such Shares shall be
delivered, free of all such restrictions, to the Participant or the Participant&#146;s beneficiary or estate, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.3. Rights of Holders of Restricted Stock (applicable to Restricted Stock, not RSUs) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided in the applicable Award Agreement, holders of Restricted Stock shall have rights as Stockholders, including voting
and dividend rights. Except as set forth in <B>Section</B><B></B><B>&nbsp;15</B>, if the Committee provides that dividends or distributions will be received by holders of Restricted Stock and any such dividends or distributions are paid in cash,
such dividends or distributions will be subject to the same provisions regarding forfeitability as the Restricted Stock with respect to which they were paid and if such dividends or distributions are paid in Shares, the Shares will be subject to the
same restrictions on transferability and forfeitability as the Restricted Stock with respect to which they were paid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.4. Purchase
of Restricted Stock (applicable to Restricted Stock, not RSUs) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Participant shall be required, to the extent required by
applicable law, to purchase the Restricted Stock from the Company at a Purchase Price equal to the greater of (i)&nbsp;the aggregate par value of the Shares represented by such Restricted Stock or (ii)&nbsp;the Purchase Price, if any, specified in
the related Award Agreement. If specified in the Award Agreement, the Purchase Price may be deemed paid by services already rendered. The Purchase Price shall be payable in a form described in <B>Section</B><B></B><B>&nbsp;11 </B>or, if so
determined by the Board, in consideration for past and future services rendered or to be rendered. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.5. Restricted Stock Certificates
(applicable to Restricted Stock, not RSUs) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to <B>Section</B><B></B><B>&nbsp;3.5</B>, the Company shall issue, in the name of
each Participant to whom Restricted Stock has been granted, stock certificates or other evidence of ownership representing the total number of Shares of Restricted Stock granted to the Participant, as soon as reasonably practicable after the Grant
Date. The Board may provide in an Award Agreement that either (i)&nbsp;the Secretary of the Company shall hold any stock certificates for the Participant&#146;s benefit until such time as the Restricted Stock is forfeited to the Company or the
restrictions lapse or (ii)&nbsp;such certificates shall be delivered to the Participant; <I>provided</I>, <I>however</I>, that such certificates shall bear a legend or legends that comply with the applicable securities laws and regulations and make
appropriate reference to the restrictions imposed under the Plan and the Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.6. Rights of Holders of RSUs (applicable
to RSUs, not Restricted Stock) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>10.6.1. Settlement of RSUs</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">RSUs may be settled in cash or Shares, as set forth in the Award Agreement. The Award Agreement shall also set forth whether the RSUs shall be
settled (i)&nbsp;within the time period specified in Section&nbsp;409A for short term deferrals or another exemption from Section&nbsp;409A or (ii)&nbsp;otherwise within the requirements of Section&nbsp;409A, in which case the Award Agreement shall
specify upon which events such RSUs shall be settled to the extent required under Section&nbsp;409A. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>10.6.2. Voting and Dividend Rights</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided in the applicable Award Agreement, holders of RSUs shall not have rights as Stockholders, including voting or
dividend or dividend equivalents rights. Except as set forth in <B>Section</B><B>&nbsp;15</B>, if the Committee provides that dividends or distributions will be received by holders of RSUs and any such dividends or distributions are paid in cash,
such dividends or distributions will be subject to the same provisions regarding forfeitability as the RSUs with respect to which they were paid and if such dividends or distributions are paid in Shares, the Shares will be subject to the same
restrictions on transferability and forfeitability as the RSUs with respect to which they were paid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>10.6.3. Creditor&#146;s
Rights</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">A holder of RSUs shall have no rights other than those of a general creditor of the Company. RSUs represent an unfunded and
unsecured obligation of the Company, subject to the terms of the applicable Award Agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>FORM OF PAYMENT FOR OPTIONS AND RESTRICTED STOCK </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11.1. General Rule </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payment of the Option Price for the Shares purchased pursuant to the exercise of an Option or the Purchase Price for Restricted Stock shall be
made in cash or in cash equivalents acceptable to the Company, except as provided in this <B>Section</B><B></B><B>&nbsp;11</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11.2.
Surrender of Shares </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent the Award Agreement so provides, payment of the Option Price for Shares purchased pursuant to the
exercise of an Option or the Purchase Price for Restricted Stock may be made all or in part through the tender to the Company of Shares, which Shares shall be valued, for purposes of determining the extent to which the Option Price or Purchase Price
for Restricted Stock has been paid thereby, at their Fair Market Value on the date of exercise or surrender. Notwithstanding the foregoing, in the case of an Incentive Stock Option, the right to make payment in the form of already-owned Shares may
be authorized only at the time of grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11.3. Cashless Exercise </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to an Option only (and not with respect to Restricted Stock), to the extent permitted by law and to the extent the Award
Agreement so provides, payment of the Option Price may be made all or in part by delivery (on a form acceptable to the Company) of an irrevocable direction to a licensed securities broker acceptable to the Company to sell Shares and to deliver all
or part of the sales proceeds to the Company in payment of the Option Price and any withholding taxes described in <B>Section</B><B></B><B>&nbsp;17.3</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11.4. Other Forms of Payment </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent the Award Agreement so provides, payment of the Option Price or the Purchase Price for Restricted Stock may be made in any other
form that is consistent with applicable laws, regulations and rules, including the Company&#146;s withholding of Shares otherwise due to the applicable Participant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>TERMS AND CONDITIONS OF PERFORMANCE AWARDS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.1. Performance Conditions </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The right of a Participant to exercise or receive a grant or settlement of any Award, and the timing thereof, may be subject to such
performance conditions as may be specified by the Board. The Board may use such business criteria and other measures of performance as it may deem appropriate in establishing any performance conditions, and may reduce the amounts payable under any
Award subject to performance conditions. The Board may determine that such Awards shall be granted, exercised or settled upon achievement of any one performance goal or that two or more of the performance goals must be achieved as a condition to
grant, exercise or settlement of such Awards. The Committee may determine the extent to which measurement of performance goals may exclude the impact of charges for restructuring, discontinued operations, extraordinary items, debt redemption or
retirement, asset write downs, litigation or claim judgments or settlements, acquisitions or divestitures, foreign exchange gains and losses and other extraordinary, unusual or <FONT STYLE="white-space:nowrap">non-recurring</FONT> items, and the
cumulative effects of tax or accounting changes (each as defined by generally accepted accounting principles and as identified in the Company&#146;s financial statements or other SEC filings). Performance goals may differ for such Awards granted to
any one Participant or to different Participants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>12.1.1. Settlement of Performance Awards; Other Terms</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Settlement of performance awards may be in cash, Shares, other Awards or other property. The Board may reduce the amount of a settlement
otherwise to be made in connection with such Awards. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>OTHER SHARE-BASED AWARDS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.1. Grant of Other Share-based Awards </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other Share-based Awards may be granted either alone or in addition to or in conjunction with other Awards. Other Share-based Awards may be
granted in lieu of other cash or other compensation to which a Service Provider is entitled from the Company or may be used in the settlement of amounts payable in Shares under any other compensation plan or arrangement of the Company, including any
other Company incentive compensation plan. The Board shall have the authority to determine the persons to whom and the time or times at which such Awards will be made, the number of Shares to be granted pursuant to such Awards, and all other terms
of such Awards. Unless the Board determines otherwise, any such Award shall be confirmed by an Award Agreement, which shall contain such provisions as the Board determines to be necessary or appropriate to carry out the intent of the Plan with
respect to such Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.2. Terms of Other Share-based Awards </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any Common Stock subject to Awards made under this <B>Section</B><B></B><B>&nbsp;13</B> may not be sold, assigned, transferred, pledged or
otherwise encumbered prior to the date on which the Shares are issued, or, if later, the date on which any applicable restriction, performance or deferral period lapses. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>REQUIREMENTS OF LAW </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14.1. General </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company shall not be required to sell or issue any Shares under any Award if the sale or issuance of such Shares would constitute a violation, including by the Participant, any other individual exercising an Option or the Company of any provision of
any law or regulation of any governmental authority, including any federal or state securities laws or regulations. If at any time the Board determines that the listing, registration or qualification
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of any Shares subject to an Award upon any securities exchange or under any governmental regulatory body is necessary or desirable as a condition of, or in connection with, the issuance or
purchase of such Shares, no such Shares may be issued or sold, including to the Participant or any other individual exercising an Option pursuant to such Award unless such listing, registration, qualification, consent or approval shall have been
effected or obtained free of any conditions not acceptable to the Company, and any delay caused thereby shall in no way affect the date of termination of the Award. Specifically, in connection with the Securities Act, upon the exercise of any Option
or the delivery of any Shares underlying an Award, unless a registration statement under such Act is in effect with respect to the Shares covered by such Award, the Company shall not be required to sell or issue such Shares unless the Board has
received evidence satisfactory to it that the Participant or any other individual exercising an Option may acquire such Shares pursuant to an exemption from registration under the Securities Act. The Company may, but shall in no event be obligated
to, register any securities covered hereby pursuant to the Securities Act. The Company shall not be obligated to take any affirmative action in order to cause the exercise of an Option or the issuance of Shares pursuant to the Plan to comply with
any law or regulation of any governmental authority. As to any jurisdiction that expressly imposes the requirement that an Option shall not be exercisable until the Shares covered by such Option are registered or are exempt from registration, the
exercise of such Option (under circumstances in which the laws of such jurisdiction apply) shall be deemed conditioned upon the effectiveness of such registration or the availability of such an exemption. The Committee may require the Participant to
sign such additional documentation, make such representations and furnish such information as it may consider appropriate in connection with the grant of Awards or issuance or delivery of Shares in compliance with applicable laws, rules and
regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14.2. Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During any time when the Company has a class of equity security registered under Section&nbsp;12 of the Exchange Act, it is the intent of the
Company that Awards (including the grant, exercise, vesting, amendment and/or settlement thereof) will qualify for the exemption provided by Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> under the Exchange Act. To the extent that any provision
of the Plan or Award or action by the Board or Committee does not comply with the requirements of Rule <FONT STYLE="white-space:nowrap">16b-3,</FONT> it shall be deemed inoperative to the extent permitted by law and deemed advisable by the Board,
and shall not affect the validity of the Plan or such Award. In the event that Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> is revised or replaced, the Board may modify the Plan in any respect necessary to satisfy the requirements of, or to
take advantage of any features of, the revised exemption or its replacement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14.3. Prohibition on Executive Officer Loans </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding any other provision of this Plan to the contrary, no Participant who is a Nonemployee Director or an &#147;executive
officer&#148; of the Company within the meaning of Section&nbsp;13(k) of the Exchange Act shall be permitted to make payment with respect to any Awards granted under the Plan, or continue any extension of credit with respect to such payment, with a
loan from the Company or a loan arranged by the Company in violation of Section&nbsp;13(k) of the Exchange Act. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>EFFECT OF CHANGES IN CAPITALIZATION </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>15.1. Adjustments for Changes in Capital Structure </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to any required action by the Stockholders, in the event of any change in the Common Stock effected without receipt of consideration
by the Company, whether through merger, consolidation, reorganization, reincorporation, recapitalization, reclassification, stock dividend, stock split, reverse stock split, <FONT STYLE="white-space:nowrap">split-up,</FONT> <FONT
STYLE="white-space:nowrap">split-off,</FONT> <FONT STYLE="white-space:nowrap">spin-off,</FONT> combination of shares, exchange of shares or similar change in the capital structure of the Company, or in the event of payment of a dividend or
distribution to the Stockholders in a form other than Shares (excepting normal cash dividends) that has a material effect on the Fair Market Value of the Shares, appropriate and proportionate adjustments shall be made in the number and class of
shares subject to the Plan and to any outstanding Awards, and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in the Option Price, SAR Exercise Price or Purchase Price per Share of any outstanding Awards in order to prevent dilution or enlargement of Participants&#146; rights under the Plan. For purposes
of the foregoing, conversion of any convertible securities of the Company shall not be treated as &#147;effected without receipt of consideration by the Company.&#148; If a majority of the Shares which are of the same class as the Shares that are
subject to outstanding Awards are exchanged for, converted into, or otherwise become (whether or not pursuant to a Change in Control) shares of another corporation (the &#147;<B>New Shares</B>&#148;), the Board may unilaterally amend the outstanding
Awards to provide that such Awards are for New Shares. In the event of any such amendment, the number of Shares subject to, and the Option Price, SAR Exercise Price or Purchase Price per Share of, the outstanding Awards shall be adjusted in a fair
and equitable manner. Any fractional share resulting from an adjustment pursuant to this<B> Section</B><B></B><B>&nbsp;15.1 </B>shall be rounded down to the nearest whole number and the Option Price, SAR Exercise Price or Purchase Price per share
shall be rounded up to the nearest whole cent. In no event may the exercise price of any Award be decreased to an amount less than the par value, if any, of the stock subject to the Award. The Board may also make such adjustments in the terms of any
Award to reflect, or related to, such changes in the capital structure of the Company or distributions as it deems appropriate. Adjustments determined by the Board pursuant to this <B>Section</B><B></B><B>&nbsp;15.1</B> shall be made in accordance
with Section&nbsp;409A to the extent applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>15.2. Change in Control </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>15.2.1. Consequences of a Change in Control</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Subject to the requirements and limitations of Section&nbsp;409A if applicable, the Board may provide for any one or more of the following in
connection with a Change in Control, which such actions need not be the same for all Participants: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)<B> Accelerated Vesting</B>. The
Board may provide in any Award Agreement, or in the event of a Change in Control may take such actions as it deems appropriate to provide, for the acceleration of the exercisability, vesting or settlement in connection with such Change in Control of
each or any outstanding Award or portion thereof and Shares acquired pursuant thereto upon such terms, including a Participant&#146;s Separation from Service prior to, upon, or following such Change in Control, to such extent as determined by the
Board. Notwithstanding the foregoing, the Board shall not provide for the acceleration of the vesting of an Award in connection with a dissolution or liquidation of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)<B> Assumption, Continuation or Substitution</B>. In the event of a Change in Control, the surviving, continuing, successor or purchasing
corporation or other business entity or parent thereof, as the case may be (the &#147;<B>Acquiror</B>&#148;), may, without the consent of any Participant, either assume or continue the Company&#146;s rights and obligations under each or any Award or
portion thereof outstanding immediately prior to the Change in Control or substitute for each or any such outstanding Award or portion thereof a substantially equivalent award with respect to the Acquiror&#146;s stock, as applicable. For purposes of
this <B>Section</B><B></B><B>&nbsp;15.2.1</B>, an Award denominated in Shares shall be deemed assumed if, following the Change in Control, the Award confers the right to receive, subject to the terms of the Plan and the applicable Award Agreement,
for each Share subject to the Award immediately prior to the Change in Control, the consideration (whether stock, cash, other securities or property or a combination thereof) to which a Stockholder on the effective date of the Change in Control was
entitled; <I>provided, however</I>, that if such consideration is not solely common stock of the Acquiror, the Board may, with the consent of the Acquiror, provide for the consideration to be received upon the exercise or settlement of the Award,
for each Share subject to the Award, to consist solely of common stock of the Acquiror equal in Fair Market Value to the per Share consideration received by Stockholders pursuant to the Change in Control. If any portion of such consideration may be
received by Stockholders pursuant to the Change in Control on a contingent or delayed basis, the Board may determine such Fair Market Value as of the time of the Change in Control on the basis of the Board&#146;s estimate of the present value of the
probable future payment of such consideration. Any Award or portion thereof which is neither assumed or continued by the Acquiror in connection with the Change in Control nor exercised or settled as of the time of consummation of the Change in
Control shall terminate and cease to be outstanding effective as of the time of consummation of the Change in Control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)<B> <FONT STYLE="white-space:nowrap">Cash-Out</FONT> of Awards.</B> The Board may,
without the consent of any Participant, determine that, upon the occurrence of a Change in Control, each or any Award or a portion thereof outstanding immediately prior to the Change in Control and not previously exercised or settled shall be
canceled in exchange for a payment with respect to each vested Share (and each unvested Share, if so determined by the Board) subject to such canceled Award in (i)&nbsp;cash, (ii) stock of the Company or of a corporation or other business entity a
party to the Change in Control or (iii)&nbsp;other property which, in any such case, shall be in an amount having a Fair Market Value equal to the Fair Market Value of the consideration to be paid per Share in the Change in Control, reduced by the
exercise or purchase price per Share, if any, under such Award. If any portion of such consideration may be received by Stockholders pursuant to the Change in Control on a contingent or delayed basis, the Board may determine such Fair Market Value
as of the time of the Change in Control on the basis of the Board&#146;s estimate of the present value of the probable future payment of such consideration. In the event such determination is made by the Board, the amount of such payment (reduced by
applicable withholding taxes, if any) shall be paid to Participants in respect of the vested portions of their canceled Awards as soon as practicable following the date of the Change in Control and in respect of the unvested portions of their
canceled Awards in accordance with the vesting schedules applicable to such Awards. For avoidance of doubt, if the amount determined pursuant to this <B>Section</B><B></B><B>&nbsp;15.2.1(c) </B>for an Option or SAR is zero or less, the affected
Option or SAR may be cancelled without any payment therefore. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>15.2.2. Change in Control Defined</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided in the applicable Award Agreement, a &#147;<B>Change in Control</B>&#148; means the consummation of any of the
following events: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the acquisition, other than from the Company, by any individual, entity or group (within the meaning of
Section&nbsp;13(d)(3) or Section&nbsp;14(d)(2) of the Exchange Act), other than the Company or any subsidiary, affiliate (within the meaning of Rule 144 promulgated under the Securities Act) or employee benefit plan of the Company, of beneficial
ownership (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> promulgated under the Exchange Act) of more than 50% of the combined voting power of the then outstanding voting securities of the Company entitled to vote generally
in the election of directors (the &#147;<B>Voting Securities</B>&#148;); or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) a reorganization, merger, consolidation or
recapitalization of the Company (a &#147;<B>Business Combination</B>&#148;), other than a Business Combination in which more than 50% of the combined voting power of the outstanding voting securities of the surviving or resulting entity immediately
following the Business Combination is held by the persons who, immediately prior to the Business Combination, were the holders of the Voting Securities; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) a complete liquidation or dissolution of the Company, or a sale of all or substantially all of the assets of the Company; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) during any period of 24 consecutive months, the Incumbent Directors cease to constitute a majority of the Board; &#147;<B>Incumbent
Directors</B>&#148; means individuals who were members of the Board at the beginning of such period or individuals whose election or nomination for election to the Board by the Stockholders was approved by a vote of at least a majority of the then
Incumbent Directors (but excluding any individual whose initial election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, if it is determined that an Award is subject to the requirements of Section&nbsp;409A and payable upon a Change
in Control, the Company will not be deemed to have undergone a Change in Control for purposes of the Plan unless the Company is deemed to have undergone a &#147;change in control event&#148; pursuant to the definition of such term in
Section&nbsp;409A. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>15.3. Adjustments </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Adjustments under this <B>Section</B><B></B><B>&nbsp;15</B> related to Shares or other securities of the Company shall be made by the Board.
No fractional Shares or other securities shall be issued pursuant to any such adjustment, and any fractions resulting from any such adjustment shall be eliminated in each case by rounding downward to the nearest whole Share. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>NO LIMITATIONS ON COMPANY </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The making of Awards shall not affect or limit in any way the right or power of the Company to make adjustments, reclassifications,
reorganizations or changes of its capital or business structure or to merge, consolidate, dissolve or liquidate, or to sell or transfer all or any part of its business or assets. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>TERMS APPLICABLE GENERALLY TO AWARDS </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.1. Disclaimer of Rights </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No provision in the Plan or in any Award Agreement shall be construed to confer upon any individual the right to remain in the employ or
service of the Company or any Affiliate, or to interfere in any way with any contractual or other right or authority of the Company or any Affiliate either to increase or decrease the compensation or other payments to any individual at any time, or
to terminate any employment or other relationship between any individual and the Company or any Affiliate. In addition, notwithstanding anything contained in the Plan to the contrary, unless otherwise provided in the applicable Award Agreement, no
Award shall be affected by any change of duties or position of the Participant, so long as such Participant continues to be a Service Provider. The obligation of the Company to pay any benefits pursuant to the Plan shall be interpreted as a
contractual obligation to pay only those amounts described herein, in the manner and under the conditions prescribed herein. The Plan shall in no way be interpreted to require the Company to transfer any amounts to a third party trustee or otherwise
hold any amounts in trust or escrow for payment to any Participant or beneficiary under the terms of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.2. Nonexclusivity of
the Plan </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither the adoption of the Plan nor the submission of the Plan to the Stockholders for approval shall be construed as
creating any limitations upon the right or authority of the Board or its delegate to adopt such other compensation arrangements as the Board or its delegate determines desirable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.3. Withholding Taxes </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company or an Affiliate, as the case may be, shall have the right to deduct from payments of any kind otherwise due to a Participant any
federal, state or local taxes of any kind required by law to be withheld in connection with an Award, including (i)&nbsp;with respect to the vesting of or other lapse of restrictions applicable to an Award, (ii)&nbsp;upon the issuance of any Shares
upon the exercise of an Option or SAR or (iii)&nbsp;otherwise due in connection with an Award. At the time such withholding is triggered, the Participant shall pay to the Company or the Affiliate, as the case may be, any amount that the Company or
the Affiliate may reasonably determine to be necessary to satisfy such withholding obligation. Subject to the prior approval of the Board, the Participant may elect to satisfy such obligations, in whole or in part, (i)&nbsp;by causing the Company or
the Affiliate to withhold up to the maximum number of Shares otherwise issuable to the Participant as may be necessary to satisfy such withholding obligation and permitted under relevant accounting rules without adverse consequences to the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company and its Affiliates or (ii)&nbsp;by delivering to the Company or the Affiliate Shares already owned by the Participant. The Shares so delivered or withheld shall have an aggregate fair
market value equal to such withholding obligations. A Participant who has made an election pursuant to this <B>Section</B><B></B><B>&nbsp;17.3</B> may satisfy his or her withholding obligation only with Shares that are not subject to any repurchase,
forfeiture, unfulfilled vesting or other similar requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.4. Other Provisions; Legends </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Award Agreement may contain such other terms not inconsistent with the Plan as may be determined by the Board. Any stock certificates for
any Shares issued under the Plan shall be subject to such stop-transfer orders and other restrictions as the Company in its sole discretion may deem advisable under the rules, regulations and other requirements of the SEC, any securities exchange on
which the Common Stock may then be listed and any applicable federal or state securities law, and the Company in its sole discretion may cause a legend or legends to be placed on such certificates to make appropriate reference to such restrictions.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.5. Severability </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any provision of the Plan or any Award Agreement shall be determined to be illegal or unenforceable by any court of law in any
jurisdiction, the remaining provisions hereof and thereof shall be severable and enforceable in accordance with their terms, and all provisions shall remain enforceable in any other jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.6. Governing Law </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Plan shall be governed by and construed in accordance with the internal laws of the State of Delaware without regard to the principles of conflicts of law thereof or principles of conflicts of laws of any other jurisdiction that could cause the
application of the laws of any jurisdiction other than the State of Delaware. For purposes of resolving any dispute that arises directly or indirectly in connection with the Plan, each Participant, by virtue of receiving an Award, shall be deemed to
have submitted to and consented to the exclusive jurisdiction of the State of North Carolina and to have agreed that any related litigation shall be conducted solely in the courts of Iredell County, North Carolina or the federal courts for the
United States for the Western District of North Carolina, where the Plan is made and to be performed, and no other courts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.7.
Minimum Vesting Requirements </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as specified below in this Section&nbsp;17.7, no portion of an Award (other than
(i)&nbsp;Substitute Awards, (ii)&nbsp;Shares delivered in lieu of fully vested cash obligations, and (iii)&nbsp;Awards to <FONT STYLE="white-space:nowrap">Non-employee</FONT> Directors that vest on the earlier of the one year anniversary of the date
of grant or the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year&#146;s annual meeting) will vest earlier than the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of such Award&#146;s
grant date; provided that Awards may be granted to any Service Provider without regard to the minimum vesting requirements set forth in the preceding sentence if the Shares subject to such Awards would not result in more than 5% of the maximum
aggregate number of Shares authorized for grant under the Plan. This Section&nbsp;17.7 shall not prevent accelerated vesting of any portion of an Award earlier than the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of such
Award&#146;s grant date if such acceleration is due to a Separation from Service of the relevant Participant or if such acceleration is in connection with a Change in Control, in each case to the extent otherwise permitted under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.8. Section&nbsp;409A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Awards under the Plan are intended to be exempt from the application of, or otherwise comply with the terms and conditions of,
Section&nbsp;409A, and, accordingly, to the maximum extent permitted, the Plan shall be interpreted and administered in connection with such intent. Any payments described in the Plan that are due within
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the &#147;short-term deferral period&#148; as defined in Section&nbsp;409A shall not be treated as deferred compensation unless applicable laws require otherwise. Notwithstanding anything to the
contrary in the Plan, to the extent required to avoid accelerated taxation and tax penalties under Section&nbsp;409A, amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to the Plan during the <FONT
STYLE="white-space:nowrap">six-month</FONT> period immediately following the Participant&#146;s Separation from Service shall instead be paid on the first payroll date after the <FONT STYLE="white-space:nowrap">six-month</FONT> anniversary of the
Participant&#146;s Separation from Service (or the Participant&#146;s death, if earlier). Notwithstanding the foregoing, neither the Company nor the Committee shall have any obligation to take any action to prevent the assessment of any excise tax
or penalty on any Participant under Section&nbsp;409A and neither the Company nor the Board shall have any liability to any Participant for such tax or penalty. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.9. Separation from Service </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board shall determine the effect of a Separation from Service upon Awards, and such effect shall be set forth in the applicable Award
Agreement. Without limiting the foregoing, the Board may provide in the Award Agreements at the time of grant, or any time thereafter with the consent of the Participant, the actions that will be taken upon the occurrence of a Separation from
Service, including accelerated vesting or termination, depending upon the circumstances surrounding the Separation from Service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.10. Transferability of Awards </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>17.10.1. Transfers in General</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Except as provided in <B>Section</B><B></B><B>&nbsp;17.10.2</B>, no Award shall be assignable or transferable by the Participant to whom it is
granted, other than by will or the laws of descent and distribution, and, during the lifetime of the Participant, only the Participant personally (or the Participant&#146;s personal representative) may exercise rights under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>17.10.2. Family Transfers</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If authorized in the applicable Award Agreement, a Participant may transfer, not for value, all or part of an Award (other than Incentive
Stock Options) to any Family Member. For the purpose of this <B>Section</B><B></B><B>&nbsp;17.10.2</B>, a &#147;not for value&#148; transfer is a transfer which is (i)&nbsp;a gift, (ii)&nbsp;a transfer under a domestic relations order in settlement
of marital property rights or (iii)&nbsp;a transfer to an entity in which more than 50% of the voting interests are owned by Family Members (or the Participant) in exchange for an interest in that entity. Following a transfer under this
<B>Section</B><B></B><B>&nbsp;17.10.2</B>, any such Award shall continue to be subject to the same terms as were applicable immediately prior to transfer. Subsequent transfers of transferred Awards are prohibited except to Family Members of the
original Participant in accordance with this <B>Section</B><B></B><B>&nbsp;17.10.2</B> or by will or the laws of descent and distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.11. Dividends and Dividend Equivalent Rights </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If specified in the Award Agreement, the recipient of Restricted Shares or RSUs may be entitled to receive, currently or on a deferred basis,
dividends or dividend equivalents with respect to the Common Stock or other securities covered by an Award. The terms of a dividend equivalent right may be set forth in the Award Agreement. Dividend equivalents credited to a Participant may be paid
currently or may be deemed to be reinvested in additional Shares or other securities of the Company at a price per unit equal to the Fair Market Value on the date that such dividend was paid to Stockholders. Notwithstanding the foregoing, in no
event will dividends or dividend equivalents on any Restricted Shares or RSUs that are unvested be payable before such Award has become earned and payable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.12. Data Protection </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A Participant&#146;s acceptance of an Award shall be deemed to constitute the Participant&#146;s acknowledgement of and consent to the
collection and processing of personal data relating to the Participant so that the Company and the Affiliates can fulfill their obligations and exercise their rights under the Plan and generally administer and manage the Plan. This data shall
include data about participation in the Plan and Shares offered or received, purchased or sold under the Plan and other appropriate financial and other data (such as the date on which the Awards were granted) about the Participant and the
Participant&#146;s participation in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.13. Plan Construction </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the Plan, unless otherwise stated, the following uses apply: (i)&nbsp;references to a statute or law refer to the statute or law and any
amendments and any successor statutes or laws, and to all valid and binding governmental regulations, court decisions and other regulatory and judicial authority issued or rendered thereunder, as amended, or their successors, as in effect at the
relevant time; (ii)&nbsp;in computing periods from a specified date to a later specified date, the words &#147;from&#148; and &#147;commencing on&#148; (and the like) mean &#147;from and including,&#148; and the words &#147;to,&#148;
&#147;until&#148; and &#147;ending on&#148; (and the like) mean &#147;to and including&#148;; (iii)&nbsp;indications of time of day shall be based upon the time applicable to the location of the principal headquarters of the Company; (iv)&nbsp;the
words &#147;include,&#148; &#147;includes&#148; and &#147;including&#148; (and the like) mean &#147;include, without limitation,&#148; &#147;includes, without limitation&#148; and &#147;including, without limitation&#148; (and the like),
respectively; (v)&nbsp;all references to articles and sections are to articles and sections in the Plan; (vi)&nbsp;all words used shall be construed to be of such gender or number as the circumstances and context require; (vii)&nbsp;the captions and
headings of articles and sections have been inserted solely for convenience of reference and shall not be considered a part of the Plan, nor shall any of them affect the meaning or interpretation of the Plan or any of its provisions; (viii)&nbsp;any
reference to an agreement, plan, policy, form, document or set of documents, and the rights and obligations of the parties under any such agreement, plan, policy, form, document or set of documents, shall mean such agreement, plan, policy, form,
document or set of documents as amended from time to time, and any and all modifications, extensions, renewals, substitutions or replacements thereof; and (ix)&nbsp;all accounting terms not specifically defined shall be construed in accordance with
GAAP. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Adopted by the Board: August&nbsp;10, 2023 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Approved by the Stockholders: August&nbsp;23, 2023 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Scheduled Termination Date: August&nbsp;23, 2033 </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-20 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>kequ-20230823.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 8/25/2023 8:36:50 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:kequ="http://www.kewaunee.com/20230823"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.kewaunee.com/20230823"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kequ-20230823_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="kequ-20230823_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>kequ-20230823_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 8/25/2023 8:36:50 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>kequ-20230823_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 8/25/2023 8:36:50 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="kequ-20230823.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140092478469632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 23, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">KEWAUNEE SCIENTIFIC CORP /DE/<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000055529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 23,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-5286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">38-0715562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2700 West Front Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Statesville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">28677<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">873-7202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $2.50 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">KEQU<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>d543464d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="kequ-20230823.xsd" xlink:type="simple"/>
    <context id="duration_2023-08-23_to_2023-08-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055529</identifier>
        </entity>
        <period>
            <startDate>2023-08-23</startDate>
            <endDate>2023-08-23</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2023-08-23_to_2023-08-23"
      id="Hidden_dei_EntityRegistrantName">KEWAUNEE SCIENTIFIC CORP /DE/</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2023-08-23_to_2023-08-23">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-08-23_to_2023-08-23"
      id="Hidden_dei_EntityCentralIndexKey">0000055529</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-08-23_to_2023-08-23">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-08-23_to_2023-08-23">2023-08-23</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-08-23_to_2023-08-23">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-08-23_to_2023-08-23">0-5286</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-08-23_to_2023-08-23">38-0715562</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-08-23_to_2023-08-23">2700 West Front Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-08-23_to_2023-08-23">Statesville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-08-23_to_2023-08-23">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-08-23_to_2023-08-23">28677</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-08-23_to_2023-08-23">704</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-08-23_to_2023-08-23">873-7202</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="duration_2023-08-23_to_2023-08-23">Common Stock, $2.50 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-08-23_to_2023-08-23">KEQU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-08-23_to_2023-08-23">NASDAQ</dei:SecurityExchangeName>
    <dei:WrittenCommunications contextRef="duration_2023-08-23_to_2023-08-23">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-08-23_to_2023-08-23">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-08-23_to_2023-08-23">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-08-23_to_2023-08-23">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-08-23_to_2023-08-23">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MS8$L-, 17V102RBI"&M)<>&'"4)W6]+=7D+WR"-&9EF\8K(.!-=PKCM>OXO
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MMXQ"VDP'N+\60G\VS!FV_ EB]!]02P,$%     @ ^8$95Y^@&_"Q @  X@P
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M$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ ^8$95P=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" #Y@1E7AB])9^X    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " #Y@1E7F5R<(Q &  "<)P  $P
M    @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( /F!&5<'
M5B*+3 0  (X0   8              " @0T(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " #Y@1E7GZ ;\+$"  #B#   #0
M    @ &/#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( /F!&5>7BKL<P
M !,"   +              "  6L/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M /F!&5<<.&7J/P$  #P"   /              "  500  !X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    " #Y@1E7)!Z;HJT   #X 0  &@
M@ ' $0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #Y
M@1E799!YDAD!  #/ P  $P              @ &E$@  6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     "0 ) #X"  #O$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d543464d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d543464d8k.htm">d543464d8k.htm</File>
    <File>d543464dex101.htm</File>
    <File>kequ-20230823.xsd</File>
    <File>kequ-20230823_lab.xml</File>
    <File>kequ-20230823_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d543464d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d543464d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "kequ-20230823_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "kequ-20230823_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "kequ-20230823.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "kequ",
   "nsuri": "http://www.kewaunee.com/20230823",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d543464d8k.htm",
      "contextRef": "duration_2023-08-23_to_2023-08-23",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d543464d8k.htm",
      "contextRef": "duration_2023-08-23_to_2023-08-23",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.kewaunee.com//20230823/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-23-221501-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-221501-xbrl.zip
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M)K#X3DZ&)QL>>7_GP&4([G5'F)..(+TI/QJ/%'\$ZLB3,$]ZPMMKC^X+OK/
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M]9(<,=4:AQ;_'(\6Z 4J*Z/H762P:%8XOOJ*JPL0S[2T<<"@^[,BI3N6Z B
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MAVVESX!C'LUG'#@\I;&M4SH""]5Q.A:P+,SZ>H6+"M8%;)8N/<HK='B+#.N
M"O)%DI^CPQH&B!PFG\T(\*\L9D8E!X'E+*9#E/]X1!^GEVF^QDE#/]$\VOWQ
MA^<MU_07'"34;D&C;[NW=&6E>26N(KU4%P0);%JEM(U)+QJ/INZR3MU=/!2G
MMWLZ[3I8<W ZX@9/X$UG4WLE"JQENCQ#W<R%MA+7>KEPJR[H&Q@R5D3U\;BW
MP;CVKX -D;."QQ&I.#*O*U6Q:[Y@>V<\.G4/Q:,EFI(P#IN!#83>5O/KYM8I
M4XIQL2]8A$/EW7'I^RDO9CQ R#S0!\,7Y">A@8(O,6X">E]58Y2\Z9"6B! T
MPVSO"O76**'(V-F_2>TN(EGXLM2?ZYP<:#O0/TB"2GHF3@[HMURI<V(.M8ZI
MUC?S<LQ]X%.TC**4H-<FI^;-'KCG9P^?Z$&=S(I5'7C6;*<&E5<LQEL;\09<
M!=C(T7ZZ0 \8&JOF>U&X).#)!VXV=!?=BNT4..+AEMCJO7$I[;EX>Y>GV?U(
M(\ZA>%9_7/3X#,SG: Y_JN9!N[!#._;*#)[FN#\4(@"J8-+_.E[.L.&7-^^'
MDX<_[.AV&.S@V<\JP5#<PH<U'GTF)U;TR7U8OE^?Q)$U'GV$)RMNVR(5K!2Z
M%):?F#%1FN#IS9L-7H4R!KT(:_8;S+FG'6,)YTJFBBO",L1#!CV>J>JKY@:^
M<75Q7>'WI$RC_VB!,P>F#PTV'VL8\5H5-3<!'@!-A&63BA6%OJ2I3!Q?/R6@
M *%4*&8 O5HD%2EQO%7 W%@7ZTJ#*] ^/.X7$IC+H]W'$45GJA?1SX<O=6A_
M_N[P98Q?7!17H*^5_!E78LP&G/B1" (!9U!EU&QH2U8ZRQ1>X6-5?%)SO,.;
M5;RXU293X$*'X\ZMS,UK37[T0\=0GIJ=D>$-&&RR.B]II<'A__CQ5KJ]]61[
M2/%[H B0:+\K$$M>";+_#'"K&1FCL;\H%NC%&[0O1MOH[(F)PMIKV59X\G3(
MMO\*FS7Z(RG?P9+Y,UFL[530SJ< '2XJ^D3.T>D:131-#TMW[*D*TU"%A5EC
MS175W"3B#0&KUBO"XY%JPC&:9_ A7=7A(CY+85?%! DAA6(!0@J5Q9(%PZI$
ML[_H>+M@CS"BCW(-5E.R2OT109'^4I1U/&_(7KR&YBX=-LS:PM!ATL"DHXV?
M^ R!IA-@@$ =B, B,]M_ :*I@K,O6Z)$A;M0(():G,[4G]!XZDYTR&^C>:A(
MM29QMWE4(S^HTI%+G%PG^N5ITF1_$%GI'D>MQ7&W)6'>F\ \]QJ.7Z_C^O$W
MQ_5GDDIX0?0'69P=^CD;\J1+X[D052M0"&#!HNX#&UL_3B^RQ0R,6M@J*_Z;
M0 LS^1M6+IV\^+/^3;_KASR#G0G_I*N+% 7035KXC1<L::?!^#P$XRX6A5W^
M@9GYZ.?/D_[G?X+FPYA_W+/'HPV7S)+U^47=V_RSD@8/I@M%7_DIID,>*2]L
MO _#X9]@R*BQ/5TR:"QT8: V1#!"= =?9"LP,8K64>.!WS%93K(50.J6'4>(
MOUI5S@O<&J@T15L:]40$(VS<G.U/.)#%8[,=TV&V9OBUQ+#1KLWI$%T6I1Z[
M5>K0WN2 I9_HP<\>_4,[<9;F8%I1!%UAW?B">0&&+BO*MW_+5OMX]EW==G Z
M\BTE.8A5!3(G%6)E&%3O0^7L X1C61OP,2\OKO+N ;@L:@[2<^?;\.4OI_;]
MAMBM\:A7]T8L:T6V4#$%G0)[$" HZ*1G#< [+]E5*EIZY>!'L8$ON'L#KR?B
MZU>9SI#<%LVSLJH9,XX*#9Q*F5BYJ##A9G&7LJMDLW?_.7ZB]6VBI=[+[;J$
M7E<,_3C GE56U$!O6.4#SF2W*=J!;%7<J4/[!^D.&WVR;1/RZ>/'P_9Y#9H!
MK!<'5NL-!''$YB/A8(/T$K]C/?UN42XXMF[JW.[073-A 9W"#C6/(PYA]$AD
M[YG"%6<&KC@>V=@QXIS8$3;%_")1%LE$RSV@H71)6#W@!O>\8<?+IY71/A^/
M>C>Z>J,4]RP][A84 W:JOP.%=*# 4!?8L55J#V10(MEZA1^KM:!9U$\T>'\P
M/VG:?:BF[]-RRNY>!2K0\F1[VH3JW!P.Z1GJRSYK=4U"D!C$$"P(;"3N$^6[
MQ=[CPI?&[!28L;Z'#G+* R1/ CN>YZ @Y5,"/_N[R4'!+2%L.2V" >?;^'-;
M IK<']9.Y5QGAZ1YPUYIL&(P7'V&L ^"TU.P>CRR6HVN[)8W6S:X^+AHD[
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M9BG<S[4@"<_L6KOFW'/\MT'=I+4N&BQ.WU;-9U\U]W_9Y&N-F4O6 Z^7,%N
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M[J.'>)YH@<4DSQ$RP$0"70T0O@."^QG6+(K:72NAEBL-9[RN-\4"!Z/1HH4
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MVR"QVW98^V;'HRURO+Y/,-,SCHY/WI*WN5EP;_N;I_'NRN_W]UWYG?QV?'"
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M5P/T[O7^O^#+WT__>/7R_P%02P,$%     @ ^8$95QXP;"!  P  3 L  !$
M  !K97%U+3(P,C,P.#(S+GAS9+U636_;.!"]%^A_F-5I%ZA$RT:"1(A3M$T#
M!$C3PDT7>RMH:>P0H4B5I.+XWW=(28[LQ%XG6:POICGS9MY\TB?O[TL)=VBL
MT&H<I<D@ E2Y+H2:CZ/:QMSF0D3O3]^^.?DCCN'L_.(*8KAQKK(98XO%(BEF
M0EDM:T<6;)+KDD$<=_J?KG_ WXWU#"8HD5N$DEN'!C[60A;9<# <ING@*#GL
MPPQR;P\*[C"#(S8\8*0X@J-L=)@=#.#;%_@<K"BX%B7VH;I:&C&_<?!G_A<$
MT)E6"J7$)9P+Q54NN(3O'>-W<*'R!#Y("1,/LT33HKG#(FFMWMLBL_D-EOSM
M&P#*E[*9(I-U.8Y\(MH\W$^-3+29L\(9YI85,E**20N-R*,>]-]QCS!4""^Q
M*^",VVD =1*?GF$/<8N_ZC4WM[C@M4(,%?)I&1P-1SU @6*E'RA9S).YOF,D
MV#3NY>+I((:#P8A10SC*,_8@4JC;'0@OGE)O])T\@BQ& 9 >'Q^S(-V@5+CU
M"%KK!ZP1!FWNG!'3VN&Y-N49SG@M"56K7S678B:P"%K4J"4JMZ:SKN&XF:.[
MXB7:BN?XK%130ST5%U%-V3]?+K^'7HM./0 @M)\H*VT<-%UXJ?,P'#O2Z7_%
M715B?Q6GPWB4)F0L O4DZRTE!/9J(EUQ7T1DU1E[$[';.M@?8G_8YOWIOG]Q
M!C8'VL=_[.-/#_>*_]%"^ ^8:'7U6C*]K?;RFB@N\F9I-<?]Z_* ?%5O=EO!
MY^%@I^/--=)Z#3ZY4MH%1WTFO*J$FNGVBBY]$V==)T]P!F%]9=SD1DO<O>18
M972%Q@E:\@_#T!BX,3@;1W[7Q]V>^2GY-*$]TZD\<K ^7E[,"(+R\H%>AW7"
M>?"E%X.7TVO)Y<JT;X=Q9"GOLC>>_W.XE<'GADL02]L]E&U[U-]Z6L\.WONY
M)@WPAQ^3B^WOP^J!8([?:Z7+94/R3.>U?X.Z[P^J^*R(VO*".LN4@58$@EZ2
M":G_W$M]1;*C62#]>1.A?=.!_]!_N\Y"_\A5 8TYZ-D[89M&-NW7%HNOZC2<
M<R[S6JZ2WH);C5W S7+MCWQ@MAW7WG8%Z\:8;<YQ>].?]^:JV3?T\S=02P,$
M%     @ ^8$95^<*VD!?!@  OD,  !4   !K97%U+3(P,C,P.#(S7VQA8BYX
M;6S-G&]OVS80QM\7Z'>X>6\VH+)C!RT:HVF1.<D0+&V"Q-V&#4,A2XQ-C"(-
M4D[L;S]2?QHYIF0I/$UYT521[IZ[Q_D=+4M*/GQ:1PSNB514\./>L'_0 \(#
M$5(^/^ZME.>K@-(>J-CGH<\$)\>]#5&]3Q]?O_KP@^?!Z?G%%_!@$<=+-1X,
M'AX>^N$=Y4JP5:PE53\0T0 \+X^?3+_"[VFY,=P01GQ%(/)53"3\LJ(L'(\.
M1J/A\.!]_UTQ31+?Z$'HQV0,[P>CMP,=> COQX?OQF\/X/HSG"4J'*8T(L54
ML=Q(.E_$\%/P,R1)IX)SPAC9P#GE/@^HS^ V[_@-7/"@#R>,P8U)4[I-1>0]
M"?N9*J/\W['Y,C/-P^M7 /I5Y"K9=]PSKT7V4JQGDO6%G.M>#PX'>4KO,6.]
MD_)PF"0,CXZ.!LG18K2BME@M/AS\^?GR-EB0R/?TJZ]_6D%61M&Q2O9?BB!Y
M"6LT"*41YCLO#_/,+F\X\@Z'_;4*>Q]-P>S5\6>$7>HM2#R,I6"DHK YG%3O
M9?'Q9JGCR3HF/"29\G=M$611"TGN4E7#7B*I2-"?B_M!2*@!9&0V/+-A.OQ1
M?_-M(C3N)S,52S^(M^LQ\Q()F>],3!SW+$F#[89,W(D,MK1\&>0Z>G./_RQB
M$ C]<UO&7J*8I]])$5F[R,H)R\%O;,:L;1J2]):9;L*]K[?[O*9"16.2*+&2
M&J\F/]K$S\=$&?[.M?_Y,'BL_5):U4N((I=-^W5#\HS'--[<D#DUA7C\Q8](
M73+MN1T!6FE$E,>XX%JNAT1M6@ >*X IX<QN>WT7$6[:O!O()Y%>K_6_^)SY
M\[H$/TGJ"%U[Z\)RT 56BQ 2I=^5P4@[T]E"HT4LZW:+L:Y.=!GILPM])K'^
MC6R:+:P[R9VNK&561$60^]IJ%<1=7+,2D-0 701I>6VE=<OZVJ!_-Z1/1; R
M<S/5W=<E>3NG(X"MC8O=8RZX[NH@49H+@U%V1A._S2*1-7O%P?":2"K",QZ>
MZL_E37E\DMPQF'8KHB(( U6+(#:S:0G0-< 40<.WA=:M'-?N'^-DX8('0BZ%
M3"Z5W,:ZWD2L]-J^F8BPX6>R/5*=GDC4LREJI[B?9-20QSWEV"H(247(2H*I
MB70&\C_XLIR//-\<QA"=4T:^K*(9D<TFIIC7Z7A8# C[<7?PGVKA4F[4(95'
M AJ[7PN]M9K& '7JKR]"_1Y#[VAZ<?PYU):*=(KP/FNB1K [W)7"N*3K4K!=
M"Y?[5JU8AN 9?C!&XB0,M0&5_7=).1DV&P>K0*>C4&5)[ ET'X%245S\,_TW
M^0:82G#%L<YC6K-A0?\97A#1G^C-*SD5#_Q9X!?37P+V%CLVZ!_#T)!_*MD2
M\*8," FF$"[LV :J4*_G A'SY$/!E;R6XI[RH.%GVS*-EP!\F3$;]4]BT="W
MZK;$?_KI3J.35\,=@E:L5$U" S^(XW M5.RSO^BR^84>N\)+& 6[*=L@;$6B
MC8%%M:4A2"N!+H5Y\:8]&U4#4-N+XX-0QJ D?A/@MW.Z>@S*UKC8/>;T$-2.
M#A*XR?N\4<;A%+_/K0>@:C;K!J)Y,I%=+P1O>-%P-Z\C($L-"/MQ%S#M6DAP
M)N*0J&-=/&FGWR*D39IV _66!"NI1V(XFDUIS&JOFKMY'8%::D#8C[N :M="
M C47!ZT.B;PSJ.WT6P2U2=-NH$ZE;Y[@O]U$,\'J4OHDJ2-$[:T+RT$7."U"
M2&1FRI!*.U/90J-%).MVB[-NGJV#A79+FCS?;,_M>/VT&A'E,1CKZ*X>]EJ:
M5\!YOKF]OJUK:LWFW4#^0Y>*"9^(*%KQ[*Z,JDMR27)'*%=;$15!+C!7""+1
MG%6 [1+.-+?8>!'GIMT[KLN"T8#&^@W@LZ^[H'[M<P5;9E=K<KD)41;AM!Z7
MJ&&MQM_E(==W7XI;:GEK(6[2MQNVUY*8^2 :B^0Q6O,[@O+J[J[^E8,JA8XP
MKF%*[(MTP7J?*A+>N@P4ZT!:"))*SJ"W;:((_#.=H*)_H=2*2/<!L.B\C#$H
M-V@?AIUXQ)$HT6YK,-)RK<Y'2XXJIZ21+8S[>V<1D7/]MO2K% _Q0O>R]'G#
M7P(KD>CT#E^U+;$WU/T>7X4LTDQD-\;R0I!6@JP4TCV^%FU8;O+5]5+<<:FW
MS-^=R';1]*\OZ#W_ 5!+ P04    " #Y@1E72AQ"@[@$  !\*@  %0   &ME
M<74M,C R,S X,C-?<')E+GAM;-6:77/B-A2&[W=F_X/JWK0S->9CDR9,R XE
M28=I/AC"MIW>[ C[ )J5)2K) ?Y]CPSJ8# II-N.Q04?LMZC5^>1A27[ZN,R
MY>0%E&92=()&K1X0$+%,F)AV@DR'5,>,!40;*A+*I8!.L (=?+Q^_^[JFS D
M-W?]1Q*2F3%SW8ZBQ6)12R9,:,DS@R%U+99I1,+0U>^-/I%?U\VUR1 X4 TD
MI=J (C]EC"?M9KW9;#3J%[7S;9D":N.1A!IHDXNH>19AQ1:Y:+?.VV=U,G@@
MMWD4048LA6VIG*\4F\X,^2[^GN2B&RD$< XK<L<$%3&CG#P[QS^0OHAKI,LY
M&5J91IL:U LDM4U4SL27MGT;6_/D_3N"+\RCT'EI)[#9V"1C.5:\)M44W=9;
MD1,%VYKEGFC1RB6-R\O+*#]:K*]966ULH!']_G#_',\@I2$R0&;Q3E/H)C%_
MJ[?-G47K@ZZ^9FV=1[J7<9[Z([I%#M:POT)7+;1%8:,9MAJUI4Z":]OD.JM*
M<AC"A-C/3\-^H<TOL*"9 ,B'5$Z_?M%L188NI9#I*K*:Z$;&60K"N,^N2&Z%
M86;5%Q.ITKPG <F3VIXIF'2"+_!G%KIHUL^W0PST^91 9C7'\T*S=,XA(-%6
M?^8*QXXP>>U[+"@(8&E ))"X,+8#_U&/K]=4-T-7QH4,N),W1Z8AKDWE2Y0
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M$N^.JV_[(+<IJ"G.,S\KN3 S[.2<BA.?73@0HKHT7[7M0/X/6R%7T5YJ[K'
M/C6Y/F+?[#. 6/(74$L! A0#%     @ ^8$95]HQ9#&8$@  AIH   X
M         ( !     &0U-#,T-C1D.&LN:'1M4$L! A0#%     @ ^8$95P-
MK4EW5P  !=,! !$              ( !Q!(  &0U-#,T-C1D97@Q,#$N:'1M
M4$L! A0#%     @ ^8$95QXP;"!  P  3 L  !$              ( !:FH
M &ME<74M,C R,S X,C,N>'-D4$L! A0#%     @ ^8$95^<*VD!?!@  OD,
M !4              ( !V6T  &ME<74M,C R,S X,C-?;&%B+GAM;%!+ 0(4
M Q0    ( /F!&5=*'$*#N 0  'PJ   5              "  6MT  !K97%U
G+3(P,C,P.#(S7W!R92YX;6Q02P4&      4 !0!  0  5GD

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
